Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 23
- −1 vs. Q3 2023
- Portfolio value
- $4.39B
- +$4.11B (+1,515.7%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KVUEKenvue Inc. | Stock | 182,329,550 | $3.93B | 89.5% | +182,329,550 | New | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $109.9M | 2.5% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $56.2M | 1.3% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $49.0M | 1.1% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $46.6M | 1.1% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $40.9M | 0.9% | +4,664,179+486.0% | Added | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $35.3M | 0.8% | 00.0% | Unchanged | History |
| SWAVShockwave Medical, Inc. | COM | 166,812 | $31.8M | 0.7% | +166,812 | New | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $31.5M | 0.7% | +937,317+102.8% | Added | History |
| XNCRXencor Inc | COM | 748,062 | $15.9M | 0.4% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $15.0M | 0.3% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $12.6M | 0.3% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $7.58M | 0.2% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $2.42M | 0.1% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 317,704 | $2.02M | <0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 688,595 | $1.30M | <0.1% | −40,349−5.5% | Reduced | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 299,669 | $1.05M | <0.1% | −95,165−24.1% | Reduced | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $711.1K | <0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $597.4K | <0.1% | 00.0% | Unchanged | History |
| CLSDClearside Biomedical, Inc. | COM | 169,629 | $198.5K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $31.1K | <0.1% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $14.7K | <0.1% | 00.0% | Unchanged | History |
| APLMApollomics Inc. | CL A SHS | 13,252 | $12.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (3)
Positions held at the end of Q3 2023 that are gone from this filing.